Obesity genetics in mouse and human: Back and forth, and back again

PeerJ

Volumn 2015, Issue 3, 2015, Pages

  Yazdi, Fereshteh T ^a   Clee, Susanne M ^b   Meyre, David ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Genetics; Genome wide association study; Human; Integrative biology; Knock out; Monogenic obesity; Mouse; Next generation sequencing; Polygenic obesity; Transgenic

Indexed keywords

ADAPTOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORAMBUCIL; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; ETHYLNITROSOUREA; ETS VARIANT 5; LENTIVIRUS VECTOR; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROTEIN; SINGLE MINDED HOMOLOG 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BARDET BIEDL SYNDROME; CHEMICAL MUTAGENESIS; CHROMOSOME SUBSTITUTION STRAIN; DNA MODIFICATION; FAT MASS AND OBESITY ASSOCIATED GENE; GENE; GENE EXPRESSION REGULATION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE TRAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CROSS; GENETIC MANIPULATION; GENETIC PROCEDURES; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; LINKAGE ANALYSIS; MICROINJECTION; NEURONAL GROWTH REGULATOR 1 GENE; NEXT GENERATION SEQUENCING; NIEMANN PICK C1 GENE; NONHUMAN; OBESITY; QUANTITATIVE TRAIT LOCUS; RADIATION MUTAGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALIA;

EID: 84926681615     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.856     Document Type: Article

References (314)

1. Abney M, Ober C, McPeek MS. 2002. Quantitative-trait homozygosity and association mapping and empirical genomewide significance in large, complex pedigrees: fasting serum-insulin level in the Hutterites. American Journal of Human Genetics 70(4):920-934 DOI 10.1086/339705.
2. Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD, Brown SDM. 2008. ENU mutagenesis, a way forward to understand gene function. Annual Review of Genomics and Human Genetics 9(1):49-69 DOI 10.1146/annurev.genom.9.081307.164224.
3. Agurs-Collins T, Khoury MJ, Simon-Morton D, Olster DH, Harris JR, Milner JA. 2008. Public health genomics: translating obesity genomics research into population health benefits. Obesity (Silver Spring, Md.) 16 (Suppl 3):S85-S94 DOI 10.1038/oby.2008.517.
4. Ahmad S, Rukh G, Varga TV, Ali A, Kurbasic A, Shungin D, Ericson U, Koivula RW, Chu AY, Rose LM, Ganna A, Qi Q, Stanáková A, Sandholt CH, Elks CE, Curhan G, Jensen MK, Tamimi RM, Allin KH, Jørgensen T, Brage S, Langenberg C, Aadahl M, Grarup N, Linneberg A, Paré G, Magnusson PKE, Pedersen NL, Boehnke M, Hamsten A, Mohlke KL, Pasquale LT, Pedersen O, Scott RA, Ridker PM, Ingelsson E, Laakso M, Hansen T, Qi L, Wareham NJ, Chasman DI, Hallmans G, Hu FB, Renström F, Orho-Melander M, Franks PW. 2013. Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genetics 9(7):e1003607 DOI 10.1371/journal.pgen.1003607.
5. Ahmad S, Varga T, Franks P. 2013. Gene × environment interactions in obesity: the state of the evidence. Human Heredity 75:106-115 DOI 10.1159/000351070.
6. Airik R, Slaats GG, Guo Z, Weiss A-C, Khan N, Ghosh A, Hurd TW, Bekker-Jensen S, Schrøder JM, Elledge SJ, Andersen JS, Kispert A, Castelli M, Boletta A, Giles RH, Hildebrandt F. 2014. Renal-retinal ciliopathy gene Sdccag8 regulates DNA damage response signaling. Journal of the American Society of Nephrology 25:1-11 DOI 10.1681/ASN.2013050565.
7. Allan MF, Eisen EJ, Pomp D. 2004. The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity. Obesity Research 12(9):1397-1407 DOI 10.1038/oby.2004.176.
8. An D, Toyoda T, Taylor EB, Yu H, Fujii N, Hirshman MF, Goodyear LJ. 2010. Glucose transport in mouse skeletal muscle. Diabetes 59:1358-1366 DOI 10.2337/db09-1266.
9. Andreasen CH, Andersen G. 2009. Gene-environment interactions and obesity-further aspects of genomewide association studies. Nutrition (Burbank, Los Angeles County, Calif.) 25(10):998-1003 DOI 10.1016/j.nut.2009.06.001.
10. Arya R, Duggirala R, Jenkinson CP, Almasy L, Blangero J, O'Connell P, Stern MP. 2004. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. American Journal of Human Genetics 74(2):272-282 DOI 10.1086/381717.
11. Asai M, Ramachandrappa S, Joachim M, Shen Y, Zhang R, Nuthalapati N, Ramanathan V, Strochlic DE, Ferket P, Linhart K, Ho C, Novoselova TV, Garg S, Ridderstrale M, Marcus C, Hirschhorn JN, Keogh JM, O'Rahilly S, Chan LF, Clark AJ, Farooqi IS, Majzoub JA. 2013. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 341(6143):275-278 DOI 10.1126/science.1233000.
12. Atwood LD, Heard-Costa NL, Cupples LA, Jaquish CE, Wilson PWF, D'Agostino RB. 2002. Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. American Journal of Human Genetics 71(5):1044-1050 DOI 10.1086/343822.
13. Ayala JE, Samuel VT, Morton GJ, Obici S, Croniger CM, Shulman GI, Wasserman DH, McGuinness OP. 2010. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease Models and Mechanisms 3(9-10):525-534 DOI 10.1242/dmm.006239.
14. Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB, Gralinski LE, Bell TA, Didion JD, Hua K, Nehrenberg DL, Powell CL, Steigerwalt J, Xie Y, Kelada SNP, Collins FS, Yang IV, Schwartz DA, Branstetter LA, Chesler EJ, Miller DR, Spence J, Liu EY, McMillan L, Sarkar A, Wang J, Wang W, Zhang Q, Broman KW, Korstanje R, Durrant C, Mott R, Iraqi FA, Pomp D, Threadgill D, Pardo-Manuel de Villena F, Churchill GA. 2011. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Research 21(8):1213-1222 DOI 10.1101/gr.111310.110.
15. Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S, Bader PI, Hamati A, Reitnauer PJ, Smith R, Stockton DW, Muhle H, Helbig I, Eichler EE, Ballif BC, Rosenfeld J, Tsuchiya KD. 2010. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genetics in Medicine 12(10):641-647 DOI 10.1097/GIM.0b013e3181ef4286.
16. Bahreini N, Noor MI, Koon PB, Talib RA, Lubis SH, Dashti MG, Salehi-Abargouei A, Esmaillzadeh A. 2013. Weight status among Iranian adolescents: comparison of four different criteria. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences 18(8):641-646.
17. Beales P. 2010. Obesity in single gene disorder. In: Genes and obesity. New York: Academic Press, 125-147.
18. Belizário JE, Akamini P, Wolf P, Strauss B, Xavier-Neto J. 2012. New routes for transgenesis of the mouse. Journal of Applied Genetics 53(3):295-315 DOI 10.1007/s13353-012-0096-y.
19. Bennett HP. 1986. Biosynthetic fate of the amino-terminal fragment of pro-opiomelanocortin within the intermediate lobe of the mouse pituitary. Peptides 7(4):615-622 DOI 10.1016/0196-9781(86)90036-7.
20. Benzinou M, Creemers JWM, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B, Balkau B, Tichet J, Marre M, Potoczna N, Horber F, Le Stunff C, Czernichow S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Andersen G, Kiess W, Körner A, Kovacs P, Jacobson P, Carlsson LMS, Walley AJ, Jørgensen T, Hansen T, Pedersen O, Meyre D, Froguel P. 2008. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nature Genetics 40(8):943-945 DOI 10.1038/ng.177.
21. Berndt SI, Gustafsson S, Mägi R, Ganna A, Wheeler E, Feitosa MF, Justice AE, Monda KL, Croteau-Chonka DC, Day FR, Esko T, Fall T, Ferreira T, Gentilini D, Jackson AU, Luan J, Randall JC, Vedantam S, Willer CJ, Winkler TW, Wood AR, Workalemahu T, Hu Y-J, Lee SH, Liang L, Lin D-Y, Min JL, Neale BM, Thorleifsson G, Yang J, Albrecht E, Amin N, Bragg-Gresham JL, Cadby G, den Heijer M, Eklund N, Fischer K, Goel A, Hottenga J-J, Huffman JE, Jarick I, Johansson Å, Johnson T, Kanoni S, Kleber ME, König IR, Kristiansson K, Kutalik Z, Lamina C, Lecoeur C, Li G, Mangino M, McArdle WL, Medina-Gomez C, Müller-Nurasyid M, Ngwa JS, Nolte IM, Paternoster L, Pechlivanis S, Perola M, Peters MJ, Preuss M, Rose LM, Shi J, Shungin D, Smith AV, Strawbridge RJ, Surakka I, Teumer A, Trip MD, Tyrer J, Van Vliet-Ostaptchouk JV, Vandenput L, Waite LL, Zhao JH, Absher D, Asselbergs FW, Atalay M, Attwood AP, Balmforth AJ, Basart H, Beilby J, Bonnycastle LL, Brambilla P, Bruinenberg M, Campbell H, Chasman DI, Chines PS, Collins FS, Connell JM, CooksonWO, de Faire U, de Vegt F, Dei M, Dimitriou M, Edkins S, Estrada K, Evans DM, Farrall M, Ferrario MM, Ferriéres J, Franke L, Frau F, Gejman PV, Grallert H, Grönberg H, Gudnason V, Hall AS, Hall P, Hartikainen A-L, Hayward C, Heard-Costa NL, Heath AC, Hebebrand J, Homuth G, Hu FB, Hunt SE, Hyppönen E, Iribarren C, Jacobs KB, Jansson J-O, Jula A, Kähönen M, Kathiresan S, Kee F, Khaw K-T, Kivimäki M, Koenig W, Kraja AT, Kumari M, Kuulasmaa K, Kuusisto J, Laitinen JH, Lakka TA, Langenberg C, Launer LJ, Lind L, Lindström J, Liu J, Liuzzi A, Lokki M-L, Lorentzon M, Madden PA, Magnusson PK, Manunta P, Marek D, März W, Leach IM, McKnight B, Medland SE, Mihailov E, Milani L, Montgomery GW, Mooser V, Mühleisen TW, Munroe PB, Musk AW, Narisu N, Navis G, Nicholson G, Nohr EA, Ong KK, Oostra BA, Palmer CNA, Palotie A, Peden JF, Pedersen N, Peters A, Polasek O, Pouta A, Pramstaller PP, Prokopenko I, Pütter C, Radhakrishnan A, Raitakari O, Rendon A, Rivadeneira F, Rudan I, Saaristo TE, Sambrook JG, Sanders AR, Sanna S, Saramies J, Schipf S, Schreiber S, Schunkert H, Shin S-Y, Signorini S, Sinisalo J, Skrobek B, Soranzo N, Stanáková A, Stark K, Stephens JC, Stirrups K, Stolk RP, Stumvoll M, Swift AJ, Theodoraki EV, Thorand B, Tregouet D-A, Tremoli E, Van der Klauw MM, van Meurs JBJ, Vermeulen SH, Viikari J, Virtamo J, Vitart V, Waeber G, Wang Z, Widén E, Wild SH, Willemsen G, Winkelmann BR, Witteman JCM, Wolffenbuttel BHR, Wong A, Wright AF, Zillikens MC, Amouyel P, Boehm BO, Boerwinkle E, Boomsma DI, Caulfield MJ, Chanock SJ, Cupples LA, Cusi D, Dedoussis GV, Erdmann J, Eriksson JG, Franks PW, Froguel P, Gieger C, Gyllensten U, Hamsten A, Harris TB, Hengstenberg C, Hicks AA, Hingorani A, Hinney A, Hofman A, Hovingh KG, HveemK, Illig T, Jarvelin M-R, Jöckel K-H, Keinanen-Kiukaanniemi SM, Kiemeney LA, Kuh D, Laakso M, Lehtimäki T, Levinson DF, Martin NG, Metspalu A, Morris AD, Nieminen MS, Njølstad I, Ohlsson C, Oldehinkel AJ, Ouwehand WH, Palmer LJ, Penninx B, Power C, Province MA, Psaty BM, Qi L, Rauramaa R, Ridker PM, Ripatti S, Salomaa V, Samani NJ, Snieder H, Sørensen TIA, Spector TD, Stefansson K, Tönjes A, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Vollenweider P, Wallaschofski H, Wareham NJ, Watkins H, Wichmann H-E, Wilson JF, Abecasis GR, Assimes TL, Barroso I, Boehnke M, Borecki IB, Deloukas P, Fox CS, Frayling T, Groop LC, Haritunian T, Heid IM, Hunter D, Kaplan RC, Karpe F, Moffatt MF, Mohlke KL, O'Connell JR, Pawitan Y, Schadt EE, Schlessinger D, Steinthorsdottir V, Strachan DP, Thorsteinsdottir U, van Duijn CM, Visscher PM, Di Blasio AM, Hirschhorn JN, Lindgren CM, Morris AP, Meyre D, Scherag A, McCarthy MI, Speliotes EK, North KE, Loos RJF, Ingelsson E. 2013. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nature Genetics 45(5):501-512 DOI 10.1038/ng.2606.
22. Bessesen DH. 2008. Update on obesity. The Journal of Clinical Endocrinology and Metabolism 93(6):2027-2034 DOI 10.1210/jc.2008-0520.
23. Biebermann H, Castañeda TR, van Landeghem F, von Deimling A, Escher F, Brabant G, Hebebrand J, Hinney A, Tschöp MH, Grüters A, Krude H. 2006. A role for beta-melanocytestimulating hormone in human body-weight regulation. Cell Metabolism 3(2):141-146 DOI 10.1016/j.cmet.2006.01.007.
24. Boch J. 2011. News and views TALEs of genome targeting A mucosal gateway for vaccines. Nature Biotechnology 29(2):135-136 DOI 10.1038/nbt0211-135.
25. Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K, Saeed S, Hamilton-Shield J, Clayton-Smith J, O'Rahilly S, Hurles ME, Farooqi IS. 2010. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463(7281):666-670 DOI 10.1038/nature08689.
26. Bonaglia MC, Ciccone R, Gimelli G, Gimelli S, Marelli S, Verheij J, Giorda R, Grasso R, Borgatti R, Pagone F, Rodr`iguez L, Martinez-Frias M-L, van Ravenswaaij C, Zuffardi O. 2008. Detailed phenotype-genotype study in five patients with chromosome 6q16 deletion: narrowing the critical region for Prader-Willi-like phenotype. European Journal of Human Genetics 16(12):1443-1449 DOI 10.1038/ejhg.2008.119.
27. Bonnefond A, Raimondo A, Stutzmann F, Ghoussaini M, Ramachandrappa S, Bersten DC, Durand E, Vatin V, Balkau B, Lantieri O, Raverdy V, Pattou F, Van Hul W, Van Gaal L, Peet DJ, Weill J, Miller JL, Horber F, Goldstone AP, Driscoll DJ, Bruning JB, Meyre D, Whitelaw ML, Froguel P. 2013. Brief report loss-of-function mutations in SIM1 contribute to obesity Prader-Willi-like features. Journal of Clinical Investigation 123(7):3037-3041 DOI 10.1172/JCI68035DS1.
28. Borman AD, Pearce LR, Mackay DS, Nagel-Wolfrum K, Davidson AE, Henderson R, Garg S, WaseemNH, Webster AR, Plagnol V, Wolfrum U, Farooqi IS, Moore AT. 2014. A homozygous mutation in the TUB gene associated with retinal dystrophy and obesity. Human Mutation 35(3):289-293 DOI 10.1002/humu.22482.
29. Boston BA, Blaydon KM, Varnerin J, Cone RD. 1997. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278(5343):1641-1644 DOI 10.1126/science.278.5343.1641.
30. Brown CY, Sadlon T, Gargett T, Melville E, Zhang R, Drabsch Y, Ling M, Strathdee CA, Gonda TJ, Barry SC. 2010. Robust reversible gene knockdown using a sing lentiviral short hairpin RNA vector. Human Gene Therapy 21:1005-1017 DOI 10.1089/hum.2009.107.
31. Buchner DA, Geisinger JM, Glazebrook PA, Morgan MG, Nadeau JH. 2012. The juxtaparanodal proteins CNTNAP2 and TAG1 regulate dietinduced obesity. Mammalian Genome 23(0):431-442 DOI 10.1007/s00335-012-9400-8.
32. Bultman SJ, Michaud EJ, Woychik RP. 1992. Molecular characterization of the mouse agouti locus. Cell 71(7):1195-1204 DOI 10.1016/S0092-8674(05)80067-4.
33. Butler AA, Kesteson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD. 2000. A unique metabolic syndrome causes obesity in the Melanocortin-3 receptor-deficient mouse. Endocrinology 141(9):3518-3521 DOI 10.1210/endo.141.9.7791.
34. Butler A, Kozak LP. 2010. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59(2):323-329 DOI 10.2337/db09-1471.
35. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR, Bromberg Y, Pennacchio LA, Dent R, McPherson R, Ahituv N, Vaisse C. 2009. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Human Molecular Genetics 18(6):1140-1147 DOI 10.1093/hmg/ddn431.
36. Carroll K, Gomez C, Shapiro L. 2004. Tubby proteins: the plot thickens. Nature Reviews. Molecular Cell Biology 5(1):55-63 DOI 10.1038/nrm1278.
37. Casola S. 2010. Mouse models for miRNA expression: the ROSA26 locus. Methods in Molecular Biology 667:145-163.
38. Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, Bernhardt U, Dreja T, Vogel H, Schmolz K, Kluge R, Zierath JR, Hultschig C, Hoeben RC, Schürmann A, Joost H-G, Al-Hasani H. 2008. Tbc1d1 mutation in lean mouse strain confers leanness protects from diet-induced obesity. Nature Genetics 40(11):1354-1359 DOI 10.1038/ng.244.
39. Challis BG, Pritchard LE, Creemers JWM, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GSH, Bhattacharyya S, Froguel P, White A, Sadaf Farooqi I, O'Rahilly S. 2002. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Human Molecular Genetics 11(17):1997-2004 DOI 10.1093/hmg/11.17.1997.
40. Chan LF, Webb TR, Chung T-T, Meimaridou E, Cooray SN, Guasti L, Chapple JP, Egertova M, Elphick MR, Cheetham ME, Metherell LA, Clark AJL. 2009. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proceedings of the National Academy of Sciences of the United States of America 106(15):6146-6151 DOI 10.1073/pnas.0809918106.
41. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, More KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84(3):491-495 DOI 10.1016/S0092-8674(00)81294-5.
42. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, EuanMacIntyre D, Howard Y, Chen LHT, Van der Ploeg. 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nature Genetics 26(1):97-102 DOI 10.1038/79254.
43. Chiu S, Diament A, Fisler J, Warden C. 2006. Gene-gene epistasis and gene-environment interactions influence diabetes and obesity. In: Nutritional genomics: discovering the path to personalized nutrition. New York: John Wiley & Sons, 135-151.
44. Choquet H, Meyre D. 2011. Genetics of obesity: what have we learned? Current Genomics 12(3):169-179 DOI 10.2174/138920211795677895.
45. Church C, Lee S, Bagg EAL, McTaggart JS, Deacon R, Gerken T, Lee A, Moir L, Mecinov J, Quwailid MM, Schofield CJ, Ashcroft FM, Cox RD. 2009. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genetics 5(8):e1000599 DOI 10.1371/journal.pgen.1000599.
46. Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L, Wells S, Brüning JC, Nolan PM, Ashcroft FM, Cox RD. 2010. Overexpression of Fto leads to increased food intake results in obesity. Nature Genetics 42(12):1086-1092 DOI 10.1038/ng.713.
47. Cirillo G, Marini R, Ito S, Wakamatsu K, Scianguetta S, Bizzarri C, Romano A, Grandone A, Perrone L, Cappa M, Miraglia del Giudice E. 2012. Lack of red hair phenotype in a North-African obese child homozygous for a novel POMC null mutation: nonsense-mediated decay RNA evaluation hair pigment chemical analysis. The British Journal of Dermatology 167(6):1393-1395 DOI 10.1111/j.1365-2133.2012.11060.
48. Clee SM, Attie AD. 2007. The genetic landscape of type 2 diabetes in mice. Endocrine Reviews 28(1):48-83 DOI 10.1210/er.2006-0035.
49. Clément K, Dubern B, Mencarelli M, Czernichow P, Ito S, Wakamatsu K, Barsh GS, Vaisse C, Leger J. 2008. Unexpected endocrine features normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. The Journal of Clinical Endocrinology and Metabolism 93(12):4955-4962 DOI 10.1210/jc.2008-1164.
50. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte J-M, Basdevant A, Bougnéres P, Lebouc Y, Froguel P, Guy-Grand B. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392(6674):398-401 DOI 10.1038/32911.
51. Coleman DL. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9(4):294-298 DOI 10.1007/BF01221857.
52. Coleman DL. 1982. Diabetes-obesity syndromes in mice. Diabetes 31:1-6 DOI 10.2337/diab.31.1.S1.
53. Coleman DL, Eicher EM. 1990. Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. The Journal of Heredity 81(6):424-427.
54. Coleman DL, Hummel KP. 1967. Studies with the mutation, diabetes, in the mouse. Diabetologia 3(2):238-248 DOI 10.1007/BF01222201.
55. Coleman DL, Hummel K. 1973. The influence of genetic background on the expression of the obese. Diabetologia 9:287-293 DOI 10.1007/BF01221856.
56. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819-823 DOI 10.1126/science.1231143.
57. Couturier C, Sarkis C, Seron K, Belouzard S, Chen P, Lenain A, Corset L, Dam J, Vauthier V, Dubart A, Mallet J, Froguel P, Rouille Y, Jockers R. 2007. Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 104(49):19476-19481 DOI 10.1073/pnas.0706671104.
58. Cox RD, Church CD. 2011. Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity. Disease Models and Mechanisms 4(2):155-164 DOI 10.1242/dmm.000414.
59. Creemers JWM, Choquet H, Stijnen P, Vatin V, Pigeyre M, Beckers S, Meulemans S, Than ME, Yengo L, Tauber M, Balkau B, Elliott P, Jarvelin M-R, Van Hul W, Van Gaal L, Horber F, Pattou F, Froguel P, Meyre D. 2012. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes 61(2):383-390 DOI 10.2337/db11-0305.
60. Creemers JW, Jackson RS, Hutton JC. 1998. Molecular and cellular regulation of prohormone processing. Seminars in Cell and Developmental Biology 9(1):3-10 DOI 10.1006/scdb.1997.0195.
61. Crews ST. 1998. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes and Development 12(5):607-620 DOI 10.1101/gad.12.5.607.
62. Croft JB, Morrell D, Chase CL, Swift M. 1995. Obesity in heterozygous carriers of the gene for the Bardet-Biedl syndrome. American Journal of Medical Genetics 55(1):12-15 DOI 10.1002/ajmg.1320550105.
63. Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK. 2007. Disruption of intraflagellar transport in adult mice leads to obesity slow-onset cystic kidney disease. Current Biology 17(18):1586-1594 DOI 10.1016/j.cub.2007.08.034.
64. Davey RA, MacLean HE. 2006. Current and future approaches using genetically modified mice in endocrine research. American Journal of Physiology. Endocrinology and Metabolism 291:E429-E438 DOI 10.1152/ajpendo.00124.2006.
65. Davis RC, van Nas A, Castellani LW, Zhao Y, Zhou Z, Wen P, Yu S, Qi H, Rosales M, Schadt EE, Broman KW, Peterfy M, Lusis AJ. 2012. Systems genetics of susceptibility to obesity-induced diabetes in mice. Physiological Genomics 44(1):1-13 DOI 10.1152/physiolgenomics.00003.2011.
66. Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjogren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC. 2003. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Human Molecular Genetics 12(15):1865-1873 DOI 10.1093/hmg/ddg195.
67. Derry JMJ, Zhong H, Molony C, MacNeil D, Guhathakurta D, Zhang B, Mudgett J, Small K, El Fertak L, Guimond A, Selloum M, Zhao W, Champy MF, Monassier L, Vogt T, Cully D, Kasarskis A, Schadt EE. 2010. Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross. PLoS ONE 5(12):e14319 DOI 10.1371/journal.pone.0014319.
68. De Souza AT, Dai X, Spencer AG, Reppen T, Menzie A, Roesch PL, He Y, Caguyong MJ, Bloomer S, Herweijer H, Wolff JA, HagstromJE, Lewis DL, Linsley PS, Ulrich RG. 2006. Transcriptional phenotypic comparisons of Ppara knockout siRNA knockdown mice. Nucleic Acids Research 34(16):4486-4494 DOI 10.1093/nar/gkl609.
69. Diament AL, Fisler JS, Warden CH. 2003. Studies of natural allele effects in mice can be used to identify genes causing common human obesity. Obesity Reviews 4(4):249-255 DOI 10.1046/j.1467-789X.2003.00113.x.
70. Dickies MM. 1962. A new viable yellow mutation in the house mouse. The Journal of Heredity 53:84-86.
71. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. 2010. Rare variants create synthetic genome-wide associations. PLoS Biology 8(1):e1000294 DOI 10.1371/journal.pbio.1000294.
72. Dina C, Meyre D, Gallina S, Durand E, Körner A, Jacobson P, Carlsson LMS, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougnéres P, Kovacs P, Marre M, Balkau B, Cauchi S, Chévre J-C, Froguel P. 2007. Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genetics 39(6):724-726 DOI 10.1038/ng2048.
73. Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P. 2004. Lentivirus-based genetic manipulations of cortical neurons their optical electrophysiological monitoring in vivo. Proceedings of the National Academy of Sciences of the United States of America 101(52):18206-18211 DOI 10.1073/pnas.0407976101.
74. Do R, Kathiresan S, Abecasis GR. 2012. Exome sequencing and complex disease: practical aspects of rare variant association studies. Human Molecular Genetics 21(R1):R1-R9 DOI 10.1093/hmg/dds387.
75. Doche ME, Bochukova EG, Su H, Pearce LR, Keogh JM, Henning E, Cline JM, Saeed S, Dale A, Cheetham T, Barroso I, Argetsinger LS, O'Rahilly S, Rui L, Carter-Su C, Farooqi IS. 2012. Human SH2B1 mutations are associated with maladaptive behaviors and obesity. The Journal of Clinical Invesitigation 122(12):4732-4736 DOI 10.1172/JCI62696.
76. Dokas J, Chadt A, Nolden T, Himmelbauer H, Zierath JR, Joost H-G, Al-Hasani H. 2013. Conventional knockout of Tbc1d1 in mice impairs insulin- and AICAR-stimulated glucose uptake in skeletal muscle. Endocrinology 154(10):3502-3514 DOI 10.1210/en.2012-2147.
77. Dong H, Maddux BA, Altomonte J, Meseck M, Accili D, Terkeltaub R, Johnson K, Youngren JF, Goldfine ID. 2005. Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes 54(2):367-372 DOI 10.2337/diabetes.54.2.367.
78. Dougherty MK, Ritt DA, Zhou M, Specht S, Monson DM, Veenstra TD, Morrison DK. 2010. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Molecular and Cellular Biology 34(6):652-662.
79. Dubern B, Lubrano-Berthelier C, Mencarelli M, Ersoy B, Frelut M-L, Bouglé D, Costes B, Simon C, Tounian P, Vaisse C, Clement K. 2008. Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the alpha-melanocyte stimulating hormone domain. Pediatric Research 63(2):211-216 DOI 10.1203/PDR.0b013e31815ed62b.
80. Dudbridge F, Gusnanto A. 2008. Estimation of significance thresholds for genomewide association scans. Genetic Epidemiology 32(3):227-234 DOI 10.1002/gepi.20297.
81. Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP. 2001. A major locus for fasting insulin concentrations insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. American Journal of Human Genetics 68(5):1149-1164 DOI 10.1086/320100.
82. Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS. 1994. Neomorphic agouti mutations in obese yellow mice. Nature Genetics 8:59-65 DOI 10.1038/ng0994-59.
83. Efthimiou M, Andrianopoulos C, Stephanou G, Demopoulos NA, Nikolaropoulos SS. 2007. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N, N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro. Mutation Research 617(1-2):125-137 DOI 10.1016/j.mrfmmm.2007.01.009.
84. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK. 2000. Genomewide search for type 2 diabetes susceptibility genes in four American populations. American Journal of Human Genetics 66(6):1871-1881 DOI 10.1086/302950.
85. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494-498 DOI 10.1038/35078107.
86. Ellacott KLJ, Morton GJ, Woods SC, Tso P, Schwartz MW. 2010. Assessment of feeding behavior in laboratory mice. Cell Metabolism 12(1):10-17 DOI 10.1016/j.cmet.2010.06.001.
87. Erickson JC, Hollopeter G, Palmiter RD. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274(5293):1704-1707 DOI 10.1126/science.274.5293.1704.
88. Erikson J, Clegg K, Palmiter R. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-421 DOI 10.1038/381415a0.
89. Farooqi IS, Bullmore E, Keogh J, Gillard J, Rahilly SO, Fletcher PC. 2007a. Leptin regulates striatal regions and human eating behavior. Science 317(5843):25-27 DOI 10.1126/science.1144599.
90. Farooqi IS, Drop S, Clements A, Keogh JM, Biernacka J, Lowenbein S, Challis BG, O'Rahilly S. 2006. Heterozygosity for a POMC-null mutation increased obesity risk in humans. Diabetes 55(9):2549-2553 DOI 10.2337/db06-0214.
91. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. 1999. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 341(12):879-884 DOI 10.1056/NEJM199909163411204.
92. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T. 2003. Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene. New England Journal of Medicine 348(12):1085-1095 DOI 10.1056/NEJMoa022050.
93. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. 2002. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110(8):1093-1103 DOI 10.1172/JCI0215693.
94. Farooqi IS, O'Rahilly S. 2008. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nature Reviews Endocrinology 4:569-577.
95. Farooqi IS, Volders K, Stanhope R, Heuschkel R, White A, Lank E, Keogh J, O'Rahilly S, Creemers JWM. 2007b. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. The Journal of Clinical Endocrinology Metabolism 92(9):3369-3373 DOI 10.1210/jc.2007-0687.
96. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S. 2007c. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. The New England Journal of Medicine 356(3):237-247 DOI 10.1056/NEJMoa063988.
97. Farooqi IS, Yeo GSH, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S. 2000. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. The Journal of Clinical Investigation 106(2):271-279 DOI 10.1172/JCI9397.
98. Fawcett GL, Roseman CC, Jarvis JP, Wang B, Wolf JB, Cheverud JM. 2008. Genetic architecture of adiposity and organ weight using combined generation QTL analysis. Obesity 16(8):1861-1868 DOI 10.1038/oby.2008.300.
99. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, Rüther U. 2009. Inactivation of the Fto gene protects from obesity. Nature 458(7240):894-898 DOI 10.1038/nature07848.
100. Fisler JS, Warden CH, Pace MJ, Lusis AJ. 1993. BSB: a new mouse model of multigenic obesity. Obesity Research 1(4):271-280 DOI 10.1002/j.1550-8528.1993.tb00621.x.
101. Flint J, Eskin E. 2013. Genome wide association studies in mice. Nature Reviews Genetics 13(11):807-817 DOI 10.1038/nrg3335.
102. Frank GR, Fox J, Candela N, Jovanovic Z, Bochukova E, Levine J, Fox J, Candela N, Jovanovic Z, Bochukova E, Levine J, Papenhausen PR, O'Rahilly S, Farooqi IS. 2013. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Molecular Genetics and Metabolism 110(1-2):191-194 DOI 10.1016/j.ymgme.2013.04.005.
103. Franks PW, Mesa J-L, Harding AH, Wareham NJ. 2007. Gene-lifestyle interaction on risk of type 2 diabetes. Nutrition, Metabolism, and Cardiovascular Diseases? 17(2):104-124 DOI 10.1016/j.numecd.2006.04.001.
104. Franks PW, Roth SM. 2008. Interaction between physical activity and genetic factors in complex metabolic disease. In: Physical activity and genetic factors in complex metabolic disease. New York: Nova Publishers, 155-173.
105. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JRB, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch A-M, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin M-R, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJF, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CNA, Doney ASF, Morris AD, Smith GD, TheWellcome Trust Case Control Consortium, Hattersley AT, McCarthy MI. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826):889-894 DOI 10.1126/science.1141634.
106. Fredriksson R, Hägglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM, Levine AS, LindblomJ, Schiöth HB. 2008. The obesity gene FTO is of ancient origin up-regulated during food deprivation expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149(5):2062-2071 DOI 10.1210/en.2007-1457.
107. Freedman BD, Lee E-J, Park Y, Jameson JL. 2005. A dominant negative peroxisome proliferatoractivated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome. The Journal of Biological Chemistry 280(17):17118-17125 DOI 10.1074/jbc. M407539200.
108. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T. 1993. Molecular cloning expression gene localization of a fourth melanocortin receptor. The Journal of Biological Chemistry 268(20):15174-15179.
109. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T. 2004. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. American Journal of Human Genetics 74(3):572-581 DOI 10.1086/382490.
110. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamäki K, Chines P, Balow Jr J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB. 2000. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. American Journal of Human Genetics 67(5):1174-1185.
111. Gibson WT, Farooqi IS, Moreau M, DePaoli AM, Lawrence E, O'Rahilly S, Trussell RA. 2004. Congenital leptin deficiency due to homozygosity for the ?133G mutation: report of another case and evaluation of response to four years of leptin therapy. Journal of Clinical Endocrinology and Metabolism 89:4821-4826 DOI 10.1210/jc.2004-0376.
112. Gill R, Cheung YH, Shen Y, Lanzano P, Mirza NM, Ten S, Maclaren NK, Motaghedi R, Han JC, Yanovski JA, Leibel RL, Chung WK. 2014. Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity. Obesity 22(2):576-584 DOI 10.1002/oby.20492.
113. Gordon JW, Ruddle FH. 1981. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214(4526):1244-1246 DOI 10.1126/science.6272397.
114. Gray J, Yeo G, Hung C, Keogh J, Clayton P, Banerjee K, McAulay A, O'Rahilly S, Farooqi IS. 2006a. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. International Journal of Obesity (2005) 31(2):359-364 DOI 10.1038/sj.ijo.0803390.
115. Gray J, Yeo GSH, Cox JJ, Morton J, Adlam A-L R., Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YCL, Hodges JR, Raymond FL, O'Rahilly S, Farooqi IS. 2006b. Hyperphagia severe obesity impaired cognitive function hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55(12):3366-3371 DOI 10.2337/db06-0550.
116. Gunstad J, Schofield P, Paul R, Spitznagel M, Ronald C, Williams LM, Kohn M, Gordon E. 2006. BNDF Val66Met polymorphism associated with body mass index in healthy adults. Neuropsychobiology 53(3):153-156 DOI 10.1159/000093341.
117. Gutierrez-Aguilar R, Kim D-H, Casimir M, Dai X-Q, Pfluger PT, Park J, Haller A, Donelan E, Park J, D'Alessio D, Woods SC, MacDonald PE, Seeley RJ. 2014. The role of the transcription factor ETV5 in insulin exocytosis. Diabetologia 57(2):383-391 DOI 10.1007/s00125-013-3096-5.
118. Han JC, Liu Q-R, JonesMaryP., Levinn RL, Menzie CM, Jefferson-George KS, Adler-Wailes DC, Sanford EL, Lacbawan FL, Uhl GR, Rennert OM, Yanovski JA. 2008. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. The New England Journal of Medicine 359(9):918-927 DOI 10.1056/NEJMoa0801119.
119. Harbers K, Jahner D, Jaenisch R. 1981. Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. Nature 293:540-544 DOI 10.1038/293540a0.
120. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjørbæk C, Elmquist JK, Flier JS, Hollenberg AN. 2001. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. The Journal of Clinical Investigation 107(1):111-120 DOI 10.1172/JCI10741.
121. Herberg L, Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism: Clinical and Experimental 26(1):59-99 DOI 10.1016/0026-0495(77)90128-7.
122. Hill J. 1998. Environmental contributions to the obesity epidemic. Science 280:1371-1374 DOI 10.1126/science.280.5368.1371.
123. Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann H-E, Rief W, Schäfer H, Hebebrand J. 2007. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2(12):e1361 DOI 10.1371/journal.pone.0001361.
124. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. 2005. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 11(1):90-94 DOI 10.1038/nm1168.
125. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. 2002. A comprehensive review of genetic association studies. Genetics in Medicine: Official Journal of the American College of Medical Genetics 4(2):45-61 DOI 10.1097/00125817-200203000-00002.
126. Holder JL, Butte NF, Zinn AR. 2000. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Human Molecular Genetics 9(1):101-108 DOI 10.1093/hmg/9.1.101.
127. Holder Jr L, Zhang L, Kublaoui BM, Dileone RJ, Bair Oz, Lee OK, Zinn CH. 2004. Sim1 gene dosage modulates the homeostatic feeding response to increased dietary fat in mice. American Journal of Physiology. Endocrinology and Metabolism 287(1):E105-E113 DOI 10.1152/ajpendo.00446.2003.
128. Horvat S, Bünger L, Falconer VM, Mackay P, Law A, Bulfield G, Keightley PD. 2000. Mapping of obesity QTLs in a cross between mouse lines divergently selected on fat content. Mammalian Genome: Official Journal of the International Mammalian Genome Society 11(1):2-7 DOI 10.1007/s003350010002.
129. Hu JK, Wang X, Wang P. 2014. Testing gene-gene interactions in genome wide association studies. Genetic Epidemiology 38(2):123-134 DOI 10.1002/gepi.21786.
130. Huang S, Kamihira M. 2013. Development of hybrid viral vectors for gene therapy. Biotechnology Advances 31(2):208-223 DOI 10.1016/j.biotechadv.2012.10.001.
131. Hummel KP, Dickie MM, Coleman DL. 1966. Diabetes, a new mutation in the mouse. Science 153(3740):1127-1128 DOI 10.1126/science.153.3740.1127.
132. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88(1):131-141 DOI 10.1016/S0092-8674(00)81865-6.
133. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin M-R, Körner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Lévy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu Taka-aki, Wolowczuk I, Tsujimoto G, Froguel P. 2012. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483(7389):350-354 DOI 10.1038/nature10798.
134. Igel M, Taylor BA, Phillips SJ, Becker W, Herberg L, Joost HG. 1998. Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain. Journal of Molecular Endocrinology 21(3):337-345 DOI 10.1677/jme.0.0210337.
135. Ikeda H. 1994. KK Mouse. Diabetes Research and Clinical Practice 24:313-316 DOI 10.1016/0168-8227(94)90268-2.
136. Indo Y, Tsuruta M, Hayashida Y, Karim M, Ohta K, Kawano T, Mitsubuchi H, Tonoki H, Awaya Y, Matsuda I. 1996. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nature Genetics 13(4):485-488 DOI 10.1038/ng0896-485.
137. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Hutton JC, O'Rahilly S. 1997. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics 16:303-307 DOI 10.1038/ng0797-303.
138. Jackson RS, Creemers JWM, Farooqi IS, Raffin-Sanson M-L, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ, O'Rahilly S. 2003. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. The Journal of Clinical Invesitigation 112(10):1550-1560 DOI 10.1172/JCI200318784.
139. Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, Martinet D, Shen Y, Valsesia A, Beckmann ND, Thorleifsson G, Belfiore M, Bouquillon S, Campion D, de Leeuw N, de Vries BBA, Esko T, Fernandez BA, Fernández-Aranda F, Fernández-Real JM, Gratacos M, Guilmatre A, Hoyer J, Jarvelin M-R, Frank Kooy R, Kurg A, Le Caignec C, Männik K, Platt OS, Sanlaville D, Van Haelst MM, Villatoro Gomez S, Walha F, Wu Bai-lin, Yu Y, Aboura A, Addor M-C, Alembik Y, Antonarakis SE, Arveiler B, Barth M, Bednarek N, Béna F, Bergmann S, Beri M, Bernardini L, Blaumeiser B, Bonneau D, Bottani A, Boute O, Brunner HG, Cailley D, Callier P, Chiesa J, Chrast J, Coin L, Coutton C, Cuisset J-M, Cuvellier J-C, David A, de Freminville B, Delobel B, Delrue M-A, Demeer B, Descamps D, Didelot G, Dieterich K, Disciglio V, Doco-Fenzy M, Drunat S, Duban-Bedu B, Dubourg C, El-SayedMoustafa JS, Elliott P, Faas BHW, Faivre L, Faudet A, Fellmann F, Ferrarini A, Fisher R, Flori E, Forer L, Gaillard D, Gerard M, Gieger C, Gimelli S, Gimelli G, Grabe HJ, Guichet A, Guillin O, Hartikainen A-L, Heron D, Hippolyte L, Holder M, Homuth G, Isidor B, Jaillard S, Jaros Z, Jiménez-Murcia S, Joly Helas G, Jonveaux P, Kaksonen S, Keren B, Kloss-Brandstätter A, Knoers Nine V. A. M., Koolen DA, Kroisel PM, Kronenberg F, Labalme A, Landais E, Lapi E, Layet V, Legallic S, Leheup B, Leube B, Lewis S, Lucas J, MacDermot KD, Magnusson P, Marshall C, Mathieu-Dramard M, McCarthy MI, Meitinger T, AntoniettaMencarelli M, Merla G, Moerman A, Mooser V, Morice-Picard F, Mucciolo M, Nauck M, Coumba Ndiaye N, Nordgren A, Pasquier L, Petit F, Pfundt R, Plessis G, Rajcan-Separovic E, Paolo Ramelli G, Rauch A, Ravazzolo R, Reis A, Renieri A, Richart C, Ried JS, Rieubland C, Roberts W, Roetzer KM, Rooryck C, Rossi M, Saemundsen E, Satre V, Schurmann C, Sigurdsson E, Stavropoulos DJ, Stefansson H, Tengström C, Thorsteinsdóttir U, Tinahones FJ, Touraine R, Vallée L, van Binsbergen E, Van der Aa N, Vincent-Delorme C, Visvikis-Siest S, Vollenweider P, Völzke H, Vulto-van Silfhout AT, Waeber G, Wallgren-Pettersson C, Witwicki RM, Zwolinksi S, Andrieux J, Estivill X, Gusella JF, Gustafsson O, Metspalu A, Scherer SW, Stefansson K, Blakemore AIF, Beckmann JS, Froguel P. 2011. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478(7367):97-102 DOI 10.1038/nature10406.
140. Jelinek D, Millward V, Birdi A, Trouard TP, Heidenreich RA, GarverWS. 2010. Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Human Molecular Genetics 20(2):312-321 DOI 10.1093/hmg/ddq466.
141. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816-821 DOI 10.1126/science.1225829.
142. Justice MJ. 2000. Capitalizing on large-scale mouse mutagenesis screens. Nature Reviews. Genetics 1(2):109-115 DOI 10.1038/35038549.
143. Justice MJ, Siracusa LD, Stewart AF. 2011. Technical approaches for mouse models of human disease. Disease Models and Mechanisms 4(3):305-310 DOI 10.1242/dmm.000901.
144. Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW. 2010. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59(7):1657-1666 DOI 10.2337/db09-1582.
145. Kanasaki K, Koya D. 2011. Biology of obesity: lessons from animal models of obesity. Journal of Biomedicine and Biotechnology 2011:1-11 DOI 10.1155/2011/197636.
146. Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee K-F, Heinemann SF, Gage FH. 2002. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proceedings of the National Academy of Sciences of the United States of America 99(4):2320-2325 DOI 10.1073/pnas.042678699.
147. Kernie SG, Liebl DJ, Parada LF. 2000. BDNF regulates eating behavior and locomotor activity in mice. The EMBO Journal 19(6):1290-1300 DOI 10.1093/emboj/19.6.1290.
148. Kirk SFL, Penney TL, McHugh T-LF. 2010. Characterizing the obesogenic environment: the state of the evidence with directions for future research. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 11(2):109-117 DOI 10.1111/j.1467-789X.2009.00611.x.
149. Kirk SFL, Penney TL, Mchugh T-LF, Sharma AM. 2012. Effective weight management practice: a review of the lifestyle intervention evidence. International Journal of Obesity 36(2):178-185 DOI 10.1038/ijo.2011.80.
150. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP. 1995. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proceedings of the National Academy of Sciences of the United States of America 92(11):4728-4732 DOI 10.1073/pnas.92.11.4728.
151. Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O, Woolf EA, Tayber O, Brody T, Shu P, Hawkins F, Kennedy B, Baldini L, Ebeling C, Alperin GD, Deeds J, Lakey ND, Culpepper J, Chen H, Glücksmann-Kuis MA, Carlson GA, Duyk GM, Moore KJ. 1996. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 85(2):281-290 DOI 10.1016/S0092-8674(00)81104-6.
152. Kootstra NA, Verma IM. 2003. Gene therapy with viral vectors. Annual Review of Pharmacology and Toxicology 43:413-439 DOI 10.1146/annurev.pharmtox.43.100901.140257.
153. Kosiol C, Vinar T, da Fonseca RR, Hubisz MJ, Bustamante CD, Nielsen R, Siepel A. 2008. Patterns of positive selection in six Mammalian genomes. PLoS Genetics 4(8):e1000144 DOI 10.1371/journal.pgen.1000144.
154. Koutnikova H, Cock T-A, Watanabe M, Houten SM, Champy M-F, Dierich A, Auwerx J. 2003. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proceedings of the National Academy of Sciences of the United States of America 100(24):14457-14462 DOI 10.1073/pnas.2336090100.
155. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A. 1998. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics 19(2):155-157 DOI 10.1038/509.
156. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, Grüters A. 2003. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. The Journal of Clinical Endocrinology and Metabolism 88(10):4633-4640 DOI 10.1210/jc.2003-030502.
157. Kublaoui BM, Holder JL, Gemelli T, Zinn AR. 2006. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Molecular Endocrinology 20(10):2483-2492 DOI 10.1210/me.2005-0483.
158. Kühn R, Torres R. 2002. Cre/loxp recombination system and gene targeting. In: Clarke A, ed. Methods in molecular biology. 2nd ed. Totowa: Humana Press Inc., 175-204.
159. Lander ES, Botstein D. 1987. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 236(4808):1567-1570 DOI 10.1126/science.2884728.
160. Laplante M, Horvat S, FestucciaWT, Birsoy K, Prevorsek Z, Efeyan A, Sabatini DM. 2012. DEPTOR cell-autonomously promotes adipogenesis and its expression is associated with obesity. Cell Metabolism 16(2):202-212 DOI 10.1016/j.cmet.2012.07.008.
161. Leduc MS, Lyons M, Darvishi K, Walsh K, Sheehan S, Amend S, Cox A, Orho-Melander M, Kathiresan S, Paigen B, Korstanje R. 2011. The mouse QTL map helps interpret human genome-wide association studies for HDL cholesterol. Journal of Lipid Research 52(6):1139-1149 DOI 10.1194/jlr. M009175.
162. Lee AWS, Cox RD. 2011. Use of mouse models in studying type 2 diabetes mellitus. Expert Reviews in Molecular Medicine 13(January):e1 DOI 10.1017/S1462399410001729.
163. Lee AWS, Hengstler H, Schwald K, Berriel-Diaz M, Loreth D, Kirsch M, Kretz O, Haas CA, de Angelis MH, Herzig S, Brümmendorf T, Klingenspor M, Rathjen FG, Rozman J, Nicholson G, Cox RD, Schäfer MKE. 2012. Functional inactivation of the genome-wide association study obesity gene neuronal growth regulator 1 in mice causes a body mass phenotype. PLoS ONE 7(7):e41537 DOI 10.1371/journal.pone.0041537.
164. Lee YS, Challis BG, Thompson DA, Yeo GSH, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, Blackwood A, Hung Chiao-Chien C., Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS. 2006. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabolism 3(2):135-140 DOI 10.1016/j.cmet.2006.01.006.
165. Lentz TB, Gray SJ, Samulski RJ. 2012. Viral vectors for gene delivery to the central nervous system. Neurobiology of Disease 48(2):179-188 DOI 10.1016/j.nbd.2011.09.014.
166. Li A, Meyre D. 2013. Challenges in reproducibility of genetic association studies: lessons learned from the obesity field. International Journal of Obesity (2005) 37(4):559-567 DOI 10.1038/ijo.2012.82.
167. Li A, Meyre D. 2014. Jumping on the train of personalized medicine: a primer for non-geneticist clinicians: Part 2. Fundamental concepts in genetic epidemiology. Current Psychiatry Reviews 10(2):101-117 DOI 10.2174/1573400510666140319235334.
168. Li P, Tiwari HK, LinW-Y, Allison DB, Chung WK, Leibel RL, Yi N, Liu N. 2014. Genetic association analysis of 30 genes related to obesity in a European American population. International Journal of Obesity 38(5):724-729 DOI 10.1038/ijo.2013.140.
169. Li S, Zhao JH, Luan Jian'an, Ekelund U, Luben RN, Khaw K-T, Wareham NJ, Loos RJF. 2010. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Medicine 7(8):1-9 DOI 10.1371/journal.pmed.1000332.
170. Liang J, Fu M, Ciociola E, Chandalia M, Abate N. 2007. Role of ENPP1 on adipocyte maturation. PLoS ONE 2(9):e882 DOI 10.1371/journal.pone.0000882.
171. Lin Y, Cradick TJ, Brown MT, Deshmukh H, Ranjan P, Sarode N, Wile BM, Vertino PM, Stewart FJ, Bao G. 2014. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA guide RNA sequences. Nucleic Acids Research 42(11):7473-7485 DOI 10.1093/nar/gku402.
172. Lloyd DJ, Bohan S, Gekakis N. 2006. Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Human Molecular Genetics 15(11):1884-1893 DOI 10.1093/hmg/ddl111.
173. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J, Croteau-Chonka DC, Esko T, Fall T, Ferreira T, Gustafsson S, Kutalik Z, Luan J, Mägi R, Randall JC, Winkler TW, Wood AR, Workalemahu T, Faul JD, Smith JA, Hua Zhao J, Zhao W, Chen J, Fehrmann R, Hedman ÅK, Karjalainen J, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bolton JL, Bragg-Gresham JL, Buyske S, Demirkan A, Deng G, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Goel A, Gong J, Jackson AU, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Mangino M, Mateo Leach I, Medina-Gomez C, Medland SE, Nalls MA, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Shungin D, Stanáková A, Strawbridge RJ, Ju Sung Y, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Isaacs A, Albrecht E, Ärnlöv J, Arscott GM, Attwood AP, Bandinelli S, Barrett A, Bas IN, Bellis C, Bennett AJ, Berne C, Blagieva R, Blüher M, Böhringer S, Bonnycastle LL, Böttcher Y, Boyd HA, Bruinenberg M, Caspersen IH, Ida Chen Y-D, Clarke R, Warwick Daw E, de Craen AJM, Delgado G, et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature 518:197-206 DOI 10.1038/nature14177.
174. Loebel DAF, Hor ACC, Bildsoe HK, Tam PPL. 2014. Timed deletion of twist1 in the limb bud reveals age-specific impacts on autopod and zeugopod patterning. PLoS ONE 9(6):e98945 DOI 10.1371/journal.pone.0098945.
175. Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X, Li D, Jia W, Kang J, Pei G. 2009. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457(7233):1146-1149 DOI 10.1038/nature07617.
176. MacKay T. 2014. Epistasis and quantitative traits: using model organisms to study gene-gene interactions. Nature Reviews Genetics 15(1):22-33 DOI 10.1038/nrg3627.
177. Mackay TFC, Stone EA, Ayroles JF. 2009. The genetics of quantitative traits: challenges and prospects. Nature Reviews. Genetics 10(8):565-577 DOI 10.1038/nrg2612.
178. Maddux BA, Chang Y, Accili D, Mcguinness OP, Youngren JF, Goldfine ID, Over IDG et al. 2006. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. American Journal of Physiology, Endocrinology and Metabolism 290:746-749 DOI 10.1152/ajpendo.00298.2005.
179. Maddux BA, Goldfin ID. 2000. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 49(15):13-19 DOI 10.2337/diabetes.49.1.13.
180. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID. 1995. Membrane glycoprotein PC-1 and insulin resistance in non-insulin dependent diabetes mellitus. Nature 373:448-451 DOI 10.1038/373448a0.
181. Marg A, Sirim P, Spaltmann F, Plagge A, Kauselmann G, Buck F, Rathjen FG, Brümmendorf T. 1999. Neurotractin, a novel neurite outgrowth-promoting Ig-like protein that interacts with CEPU-1 and LAMP. Journal of Cell Biology 145(4):865-876 DOI 10.1083/jcb.145.4.865.
182. Martín MG, Lindberg I, Solorzano-Vargas RS, Wang J, Avitzur Y, Bandsma R, Sokollik C, Lawrence S, Pickett LA, Chen Z, Egritas O, Dalgic B, Albornoz V, de Ridder L, Hulst J, Gok F, Aydoan A, Al-Hussaini A, Gok DE, Yourshaw M, Wu SV, Cortina G, Stanford S, Georgia S. 2013. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology 145(1):138-148 DOI 10.1053/j.gastro.2013.03.048.
183. May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M. 2000. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406(6791):82-86 DOI 10.1038/35017565.
184. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K. 2009. A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Molecular Genetics and Metabolism 97(4):305-308 DOI 10.1016/j.ymgme.2009.04.002.
185. McClurg P, Janes J, Wu C, Delano DL, Walker JR, Batalov S, Takahashi JS, Shimomura K, Kohsaka A, Bass J, Wiltshire T, Su AI. 2007. Genomewide association analysis in diverse inbred mice: power and population structure. Genetics 176:675-683 DOI 10.1534/genetics.106.066241.
186. McMurray F, Church CD, Larder R, Nicholson G, Wells S, Teboul L, Tung YCL, Rimmington D, Bosch F, Jimenez V, Yeo GSH, O'Rahilly S, Ashcroft FM, Coll AP, Cox RD. 2013. Adult onset global loss of the fto gene alters body composition and metabolism in the mouse. PLoS Genetics 9(1):e1003166 DOI 10.1371/journal.pgen.1003166.
187. Mencarelli M, Dubern B, Alili R, Maestrini S, Benajiba L, Tagliaferri M, Galan P, Rinaldi M, Simon C, Tounian P, Hercberg S, Liuzzi A, Di Blasio AM, Clement K. 2011. Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Human Molecular Genetics 20(2):392-399 DOI 10.1093/hmg/ddq472.
188. Mendiratta MS, Yang Y, Balazs AE, Willis AS, Eng CM, Karaviti LP, Potocki L. 2011. Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation. International Journal of Pediatric Endocrinology 2011(1):5 DOI 10.1186/1687-9856-2011-5.
189. Menke DB. 2013. Engineering subtle targeted mutations into the mouse genome. Genesis 51(9):605-618 DOI 10.1002/dvg.22422.
190. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, Ghoussaini M, Wachter C, Hercberg S, Charpentier G, Patsch W, Pattou F, Charles M-A, Tounian P, Clément K, Jouret B, Weill J, Maddux BA, Goldfine ID, Walley A, Boutin P, Dina C, Froguel P. 2005. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature Genetics 37(8):863-867 DOI 10.1038/ng1604.
191. Meyre D, Delplanque J, Chévre J-C, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proença C, Gaget S, Körner A, Kovacs P, Kiess W, Tichet J, Marre M, Hartikainen A-L, Horber F, Potoczna N, Hercberg S, Levy-Marchal C, Pattou F, Heude B, Tauber M, McCarthy MI, Blakemore AIF, Montpetit A, Polychronakos C, Weill J, Coin LJM, Asher J, Elliott P, Järvelin M-R, Visvikis-Siest S, Balkau B, Sladek R, Balding D, Walley A, Dina C, Froguel P. 2009. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nature Genetics 41(2):157-159 DOI 10.1038/ng.301.
192. Meyre D, Farge M, Lecoeur C, Proenca C, Durand E, Allegaert F, Tichet J, Marre M, Balkau B, Weill J, Delplanque J, Froguel P. 2008. R125W coding variant in TBC1D1 confers risk for familial obesity contributes to linkage on chromosome 4p14 in the French population. Human Molecular Genetics 17(12):1798-1802 DOI 10.1093/hmg/ddn070.
193. Meyre D, Lecoeur C, Delplanque J, Francke S, Vatin V, Durand E, Weill J, Dina C, Froguel P. 2004. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes 53(3):803-811 DOI 10.2337/diabetes.53.3.803.
194. Michaud JL, Boucher F, Melnyk A, Gauthier F, Goshu E, Lévy E, Mitchell GA, Himms-Hagen J, Fan CM. 2001. Sim1 haploinsufficiency causes hyperphagia obesity reduction of the paraventricular nucleus of the hypothalamus. Human Molecular Genetics 10(14):1465-1473 DOI 10.1093/hmg/10.14.1465.
195. Michaud JL, DeRossi C, May NR, Holdener BC, Fan CM. 2000. ARNT2 acts as the dimerization partner of SIM1 for the development of the hypothalamus. Mechanisms of Development 90(2):253-261 DOI 10.1016/S0925-4773(99)00328-7.
196. Michaud JL, Rosenquist T, May NR, Fan CM. 1998. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes and Development 12(20):3264-3275 DOI 10.1101/gad.12.20.3264.
197. Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS. 1993. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes and Development 7(3):454-467 DOI 10.1101/gad.7.3.454.
198. Misra A, Khurana L. 2008. Obesity and the metabolic syndrome in developing countries. The Journal of Clinical Endocrinology and Metabolism 93(11 Suppl 1):S9-S30 DOI 10.1210/jc.2008-1595.
199. Mollah MBR, Ishikawa A. 2011. Intersubspecific subcongenic mouse strain analysis reveals closely linked QTLs with opposite effects on body weight. Mammalian Genome: Official Journal of the International Mammalian Genome Society 22(5-6):282-289 DOI 10.1007/s00335-011-9323-9.
200. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387(6636):903-908 DOI 10.1038/43185.
201. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ. 2004. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proceedings of the National Academy of Sciences of the United States of America 101(29):10827-10832 DOI 10.1073/pnas.0402141101.
202. Morrison AC, Voorman A, Johnson AD, Liu X, Yu J, Li A, Muzny D, Yu F, Rice K, Zhu C, Bis J, Heiss G, O'Donnell CJ, Psaty BM, Cupples LA, Gibbs R, Boerwinkle E. 2013. Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. Nature Genetics 45(8):899-901 DOI 10.1038/ng.2671.
203. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. 1999. The disease burden associated with overweight and obesity. JAMA: The Journal of the American Medical Association 282(16):1523-1529 DOI 10.1001/jama.282.16.1523.
204. Nadeau JH, Singer JB, Matin A, Lander ES. 2000. Analysing complex genetic traits with chromosome substitution strains. Nature 24:221-225.
205. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduses enzyme activity. Nature Genetics 10(2):135-142 DOI 10.1038/ng0695-135.
206. Noble EE, Billington CJ, Kotz CM, Wang C. 2011. The lighter side of BDNF. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 300(5):1053-1069 DOI 10.1152/ajpregu.00776.2010.
207. O'Kane C, Gehrin W. 1987. Detection in situ of genomic regulatory elements in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 84:9123-9127 DOI 10.1073/pnas.84.24.9123.
208. O'Rahilly S, Farooqi IS. 2008. Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 57(11):2905-2910 DOI 10.2337/db08-0210.
209. Okazaki M, Saito Y, Udaka Y, Maruyama M, Murakami H, Ota S, Kikuchi T, Oguchi K. 2002. Diabetic nephrophathy in KK and KK-Ay mice. Experimental Animals 51(2):191-196 DOI 10.1538/expanim.51.191.
210. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS. 2005. A potential decline in life expectancy in the United States in the 21st century. The New England Journal of Medicine 352(11):1138-1145 DOI 10.1056/NEJMsr043743.
211. Osten P, Dittgen T, Licznerski P. 2006. Lentivirus-based genetic manipulations in neurons in vivo. In: The dynamic synapse: molecular methods in ionotropic receptor biology. New York: CRC Press, 249-256.
212. Otto EA, Hurd TW, Airik R, Chaki M, Zhou W, Stoetzel C, Patil SB, Levy S, Ghosh AK, Murga-Zamalloa CA, van Reeuwijk J, Letteboer SJF, Sang L, Giles RH, Liu Q, Coene KLM, Estrada-Cuzcano A, Collin RWJ, McLaughlin HM, Held S, Kasanuki JM, Ramaswami G, Conte J, Lopez I, Washburn J, MacDonald J, Hu J, Yamashita Y, Maher ER, Guay-Woodford LM, Neumann HPH, Obermüller N, Koenekoop RK, Bergmann C, Bei X, Lewis RA, Katsanis N, Lopes V, Williams DS, Lyons RH, Dang CV, Brito DA, Dias MB, Zhang X, Cavalcoli JD, Nürnberg G, Nürnberg P, Pierce EA, Jackson PK, Antignac C, Saunier S, Roepman R, Dollfus H, Khanna H, Hildebrandt F. 2010. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nature Genetics 42(10):840-850 DOI 10.1038/ng.662.
213. Paigen K. 2003. One hundred years of mouse genetics: an intellectual history. I. The classical period (1902-1980). Genetics 163:1-7.
214. Parks BW, Nam E, Org E, KostemE, Norheim F, Hui ST, Pan C, Civelek M, Rau CD, Bennett BJ, Mehrabian M, Ursell LK, He A, Castellani LW, Zinker B, Kirby M, Drake TA, Drevon CA, Knight R, Gargalovic P, Kirchgessner T, Eskin E, Lusis AJ. 2013. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metabolism 17(1):141-152 DOI 10.1016/j.cmet.2012.12.007.
215. Patwari P, Emilsson V, Schadt EE, ChutkowWA, Lee S, Marsili A, Zhang Y, Dobrin R, Cohen DE, Larsen PR, Zavacki AM, Fong LG, Young SG, Lee RT. 2011. The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metabolism 14(5):671-683 DOI 10.1016/j.cmet.2011.08.011.
216. Pearce LR, Atanassova N, Banton MC, Bottomley B, Van der Klaauw AA, Revelli J-P, Hendricks A, Keogh JM, Henning E, Doree D, Jeter-Jones S, Garg S, Bochukova EG, Bounds R, Ashford S, Gayton E, Hindmarsh PC, Shield JPH, Crowne E, Barford D, Wareham NJ, UK10K consortium, O'Rahilly S, Murphy MP, Powell DR, Barroso I, Farooqi IS. 2013. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell 155(4):765-777 DOI 10.1016/j.cell.2013.09.058.
217. Pearce LR, Joe R, Doche ME, Su H-W, Keogh JM, Henning E, Argetsinger LS, Bochukova EG, Cline JM, Garg S, Saeed S, Shoelson S, O'Rahilly S, Barroso I, Rui L, Farooqi IS, Carter-Su C. 2014. Functional characterisation of obesity-associated variants involving the alpha and beta isoforms of human SH2B1. Endocrinology 155(9):3219-3226 DOI 10.1210/en.2014-1264.
218. Philip VM, Sokoloff G, Ackert-Bicknell CL, Striz M, Branstetter L, Beckmann MA, Spence JS, Jackson BL, Galloway LD, Barker P, Wymore AM, Hunsicker PR, Durtschi DC, Shaw GS, Shinpock S, Manly KF, Miller DR, Donohue KD, Culiat CT, Churchill GA, Lariviere WR, Palmer AA, O'Hara BF, Voy BH, Chesler EJ. 2011. Genetic analysis in the Collaborative Cross breeding population. Genome Research 21(8):1223-1238 DOI 10.1101/gr.113886.110.
219. Philippe J, Stijnen P, Meyre D, De Graeve F, Thuillier D, Delplanque J, Gyapay G, Sand O, Creemers JW, Froguel P, Bonnefond A. 2014. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. International Journal of Obesity 39:1-30 DOI 10.1038/ijo.2014.96.
220. Pomp D. 2007. Natural polygenic models. In: Obesity: genomics and postgenomics. New York: CRC Press, 125-142.
221. Prada PO, Quaresma PGF, Caricilli AM, Santos AC, Guadagnini D, Morari J, Weissmann L, Ropelle ER, Carvalheira JBC, Velloso LA, Saad MJA. 2013. Tub has a key role in insulin and leptin signaling and action in vivo in hypothalamic nuclei. Diabetes 62(1):137-148 DOI 10.2337/db11-1388.
222. Prevorsek Z, Gorjanc G, Paigen B, Horvat S. 2010. Congenic and bioinformatics analyses resolved a major-effect Fob3b QTL on mouse Chr 15 into two closely linked loci. Mammalian Genome: Official Journal of the International Mammalian Genome Society 21(3-4):172-185 DOI 10.1007/s00335-010-9252-z.
223. Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, Nishimura DY, Sheffield VC. 2008. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. The Journal of Clinical Invesitigation 118(4):1458-1467 DOI 10.1172/JCI32357.
224. Ramachandrappa S, Raimondo A, Cali AMG, Keogh JM, Henning E, Saeed S, Thompson A, Garg S, Bochukova EG, Brage S, Trowse V, Wheeler E, Sullivan AE, Dattani M, Clayton PE, Datta V, Bruning JB, Wareham NJ, O'Rahilly S, Peet DJ, Barroso I, Whitelaw ML, Farooqi IS. 2013. Rare variants in single-minded 1 (SIM1) are associated with severe obesity. The Journal of Clinical Invesitigation 123(7):3042-3050 DOI 10.1172/JCI68016DS1.
225. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Pérusse L, Bouchard C. 2006. The human obesity gene map: the 2005 update. Obesity 14(4):529-644 DOI 10.1038/oby.2006.71.
226. Reed DR, Lawler MP, Tordoff MG. 2008. Reduced body weight is a common effect of gene knockout in mice. BMC Genetics 9(4) DOI 10.1186/1471-2156-9-4.
227. Rees DA, Alcolado JC. 2005. Animal models of diabetes mellitus. Diabetic Medicine: A Journal of the British Diabetic Association 22(4):359-370 DOI 10.1111/j.1464-5491.2005.01499.x.
228. Ren D, Li M, Duan C, Rui L. 2005. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metabolism 2(2):95-104 DOI 10.1016/j.cmet.2005.07.004.
229. Revelli J-P, Smith D, Allen J, Jeter-Jones S, Shadoan MK, Desai U, Schneider M, Van Sligtenhorst I, Kirkpatrick L, Platt KA, Suwanichkul A, Savelieva K, Gerhardt B, Mitchell J, Syrewicz J, Zambrowicz B, Hamman BD, Vogel P, Powell DR. 2011. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity 19(5):1010-1018 DOI 10.1038/oby.2010.282.
230. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R. 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity hyperactivity. Molecular Endocrinology 15(10):1748-1757 DOI 10.1210/mend.15.10.0706.
231. Rogner UC, Avner P. 2003. Congenic mice: cutting tools for complex immune disorders. Nature Reviews. Immunology 3:243-252 DOI 10.1038/nri1031.
232. Roselli-Rehfuss KG, Mountjoy LS, Robbins MT, Mortrud MJ, Low JB, Tatro ML, Entwistle RB, Simerly RD, Cone. 1993. Identification of a receptor for gamma melanotropin other proopiomelanocortin peptides in the hypothalamus limbic system. Proceedings of the National Academy of Sciences of the United States of America 90(19):8856-8860 DOI 10.1073/pnas.90.19.8856.
233. Rosenthal N, Brown S. 2007. The mouse ascending: perspectives for human-disease models. Nature Cell Biology 9(9):993-999 DOI 10.1038/ncb437.
234. Rouskas K, Meyre D, Stutzmann F, Paletas K, Papazoglou D, Vatin V, Marchand M, Kouvatsi A, Froguel P. 2012. Loss-of-function mutations in MC4R are very rare in the Greek severely obese adult population. Obesity 20(11):2278-2282 DOI 10.1038/oby.2012.77.
235. Russell LB, Hunsicker PR, Cacheiro NL, Bangham JW, Russell WL, Shelby MD. 1989. Chlorambucil effectively induces deletion mutations in mouse germ cells. Proceedings of the National Academy of Sciences of the United States of America 86(10):3704-3708 DOI 10.1073/pnas.86.10.3704.
236. Saeed S, Butt TA, Anwer M, Arslan M, Froguel P. 2012. High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families. Molecular Genetics and Metabolism 106(1):121-126 DOI 10.1016/j.ymgme.2012.03.001.
237. Sano H, Kane S, Sano E, Miinea CP, Asara JM, LaneWS, Garner CW, Lienhard GE. 2003. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. The Journal of Biological Chemistry 278(17):14599-14602 DOI 10.1074/jbc. C300063200.
238. Scheidecker S, Etard C, Pierce NW, Geoffroy V, Schaefer E, Muller J, Chennen K, Flori E, Pelletier V, Poch O, Marion V, Stoetzel C, Strahle U, Nachury MV, Dollfus H. 2014. Exome sequencing of Bardet-Biedl syndrome patient identifies a null mutation in the BBSome subunit BBIP1 (BBS18). Journal of Medical Genetics 51(2):132-136 DOI 10.1136/jmedgenet-2013-101785.
239. Scherag A, Dina C, Hinney A, Vatin V, Scherag S, Vogel CIG, Müller TD, Grallert H, Wichmann H-E, Balkau B, Heude B, Jarvelin M-R, Hartikainen A-L, Levy-Marchal C, Weill J, Delplanque J, Körner A, Kiess W, Kovacs P, Rayner NW, Prokopenko I, McCarthy MI, Schäfer H, Jarick I, Boeing H, Fisher E, Reinehr T, Heinrich J, Rzehak P, Berdel D, Borte M, Biebermann H, Krude H, Rosskopf D, Rimmbach C, Rief W, Fromme T, Klingenspor M, Schürmann A, Schulz N, Nöthen MM, Mühleisen TW, Erbel R, Jöckel K-H, Moebus S, Boes T, Illig T, Froguel P, Hebebrand J, Meyre D. 2010. Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genetics 6(4):e1000916 DOI 10.1371/journal.pgen.1000916.
240. Scuteri A, Sanna S, ChenW-M, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR. 2007. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genetics 3(7):e115 DOI 10.1371/journal.pgen.0030115.
241. Sementchenko VI, Watson DK. 2000. Ets target genes: past, present and future. Oncogene 19(55):6533-6548 DOI 10.1038/sj.onc.1204034.
242. Seppen J, Barry SC, Harder B, Osborne WR. 2001. Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin. Blood 98(3):594-596 DOI 10.1182/blood. V98.3.594.
243. Shao H, Burrage LC, Sinasac DS, Hill AE, Ernest SR, O'Brien W, Courtland H-W, Jepsen KJ, Kirby A, Kulbokas EJ, Daly MJ, Broman KW, Lander ES, Nadeau JH. 2008. Genetic architecture of complex traits: large phenotypic effects pervasive epistasis. Proceedings of the National Academy of Sciences of the United States of America 105(50):19910-19914 DOI 10.1073/pnas.0810388105.
244. Sharrocks AD. 2001. The ETS-domain transcription factor family. Nature Reviews: Molecular Cell Biology 2(11):827-837 DOI 10.1038/35099076.
245. Sheffield V. 2010. The blind leading the obese: the molecular pathophysiology of a human obesity syndrome. Transactions of the American Clinical and Climatological Association 121:172-182.
246. Shendure J. 2011. Next-generation human genetics. Genome Biology 12(9):408 DOI 10.1186/gb-2011-12-9-408.
247. Silver L. 1995.Mouse genetics: concepts and applications. New York: Oxford University Press, 1-362.
248. Singer J, Hill A, Burrage L, Olszens K, Song J, Justice M, Nadeau J et al. 2004. Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304:445-449 DOI 10.1126/science.1093139.
249. Singleton A. 2011. Exome sequencing: a transformative technology. The Lancet Neurology 10(10):942-946 DOI 10.1016/S1474-4422(11)70196-X.
250. Smemo S, Tena JJ, Kim K-H, Gamazon ER, Sakabe NJ, Gómez-Marín C, Aneas I, Credidio FL, Sobreira DR, Wasserman NF, Lee JH, Puviindran V, Tam D, Shen M, Son JE, Vakili NA, Sung H-K, Naranjo S, Acemel RD, Manzanares M, Nagy A, Cox NJ, Hui C-C, Gomez-Skarmeta JL, Nóbrega MA. 2014. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507(7492):371-375 DOI 10.1038/nature13138.
251. Smith A, Funder J. 1988. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocrine Reviews 9(1):159-179 DOI 10.1210/edrv-9-1-159.
252. Sonestedt E, Lyssenko V, Ericson U, Gullberg B, Wirfält E, Groop L, Orho-Melander M. 2012. Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort. The Journal of Clinical Endocrinology and Metabolism 97(5):E810-E818 DOI 10.1210/jc.2011-2444.
253. Speakman J, Hambly C, Mitchell S, Król E. 2007. Animal models of obesity. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 8(Suppl 1):55-61 DOI 10.1111/j.1467-789X.2007.00319.x.
254. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Allen HL, Lindgren CM, Luan Jian'an, Mägi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segré AV, Estrada K, Liang L, Nemesh J, Park J-H, Gustafsson S, Kilpeläinen TO, Yang J, Bouatia-Naji N, Esko T, Feitosa MF, Kutalik Z, Mangino M, Raychaudhuri S, Scherag A, Smith AV, Welch R, Zhao JH, Aben KK, Absher DM, Amin N, Dixon AL, Fisher E, Glazer NL, Goddard ME, Heard-Costa NL, Hoesel V, Hottenga J-J, Johansson Å, Johnson T, Ketkar S, Lamina C, Li S, Moffatt MF, Myers RH, Narisu N, Perry JRB, Peters MJ, Preuss M, Ripatti S, Rivadeneira F, Sandholt C, Scott LJ, Timpson NJ, Tyrer JP, vanWingerden S, Watanabe RM, White CC, Wiklund F, Barlassina C, Chasman DI, Cooper MN, Jansson J-O, Lawrence RW, Pellikka N, Prokopenko I, Shi J, Thiering E, Alavere H, Alibrandi MTS, Almgren P, Arnold AM, Aspelund T, Atwood LD, Balkau B, Balmforth AJ, Bennett AJ, Ben-Shlomo Y, Bergman RN, Bergmann S, Biebermann H, Blakemore AIF, Boes T, Bonnycastle LL, Bornstein SR, Brown MJ, Buchanan TA, Busonero F, Campbell H, Cappuccio FP, Cavalcanti-Proença C, Chen Y-DI, Chen C-M, Chines PS, Clarke R, Coin L, Connell J, Day INM, HeijerMartin den, Duan J, Ebrahim S, Elliott P, Elosua R, Eiriksdottir G, Erdos MR, Eriksson JG, Facheris MF, Felix SB, Fischer-Posovszky P, FolsomAR, Friedrich N, Freimer NB, Fu M, Gaget S, Gejman PV, Geus EJC, Gieger C, Gjesing AP, Goel A, Goyette P, Grallert H, Gräßler J, Greenawalt DM, Groves CJ, Gudnason V, Guiducci C, Hartikainen A-L, Hassanali N, Hall AS, Havulinna AS, Hayward C, Heath AC, Hengstenberg C, Hicks AA, Hinney A, Hofman A, Homuth G, Hui J, Igl W, Iribarren C, Isomaa B, Jacobs KB, Jarick I, Jewell E, John U, Jørgensen T, Jousilahti P, Jula A, Kaakinen M, Kajantie E, Kaplan LM, Kathiresan S, Kettunen J, Kinnunen L, Knowles JW, Kolcic I, König IR, Koskinen S, Kovacs P, Kuusisto J, Kraft P, Kvaløy K, Laitinen J, Lantieri O, Lanzani C, Launer LJ, Lecoeur C, Lehtimäki T, Lettre G, Liu J, Lokki M-L, Lorentzon M, Luben RN, Ludwig B, Manunta P, Marek D, Marre M, Martin NG, McArdle WL, McCarthy A, McKnight B, Meitinger T, Melander O, Meyre D, Midthjell K, Montgomery GW, Morken MA, Morris AP, Mulic R, Ngwa JS, Nelis M, Neville MJ, Nyholt DR, O'Donnell CJ, O'Rahilly S, Ong KK, Oostra B, Paré G, Parker AN, Perola M, Pichler I, Pietiläinen KH, Platou CGP, Polasek O, Pouta A, Rafelt S, Raitakari O, Rayner NW, Ridderstråle M, Rief W, Ruokonen A, Robertson NR, Rzehak P, Salomaa V, Sanders AR, Sandhu MS, Sanna S, Saramies J, Savolainen MJ, Scherag S, Schipf S, Schreiber S, Schunkert H, Silander K, Sinisalo J, Siscovick DS, Smit JH, Soranzo N, Sovio U, Stephens J, Surakka I, Swift AJ, Tammesoo M-L, Tardif J-C, Teder-Laving M, Teslovich TM, Thompson JR, Thomson B, Tönjes A, Tuomi T, vanMeurs JBJ, van Ommen G-J, Vatin V, Viikari J, Visvikis-Siest S, Vitart V, Vogel CIG, Voight BF, Waite LL, Wallaschofski H, Walters GB, Widen E, Wiegand S, Wild SH, Willemsen G, Witte DR, Witteman JC, Xu J, Zhang Q, Zgaga L, Ziegler A, Zitting P, Beilby JP, Farooqi IS, Hebebrand J, Huikuri HV, James AL, Kähönen M, Levinson DF, Macciardi F, Nieminen MS, Ohlsson C, Palmer LJ, Ridker PM, Stumvoll M, Beckmann JS, Boeing H, Boerwinkle E, Boomsma DI, Caulfield MJ, Chanock SJ, Collins FS, Cupples LA, Smith GD, Erdmann J, Froguel P, Grönberg H, Gyllensten U, Hall P, Hansen T, Harris TB, Hattersley AT, Hayes RB, Heinrich J, Hu FB, HveemK, Illig T, Jarvelin M-R, Kaprio J, Karpe F, Khaw K-T, Kiemeney LA, Krude H, Laakso M, Lawlor DA, Metspalu A, Munroe PB, Ouwehand WH, Pedersen O, Penninx BW, Peters A, Pramstaller PP, Quertermous T, Reinehr T, Rissanen A, Rudan I, Samani NJ, Schwarz PEH, Shuldiner AR, Spector TD, Tuomilehto J, Uda M, Uitterlinden A, Valle TT, Wabitsch M, Waeber G, Warm NJ, Watkins H, Wilson JF, Wright AF, Zillikens MC, Chatterjee N, McCarroll SA, Purcell S, Schadt EE, Visscher PM, Assimes TL, Borecki IB, Deloukas P, Fox CS, Groop LC, Haritunians T, Hunter DJ, Kaplan RC, Mohlke KL, O'Connell JR, Peltonen L, Schlessinger D, Strachan DP, van Duijn CM, Wichmann H-E, Frayling TM, Thorsteinsdottir U, Abecasis GR, Barroso I, Boehnke M, Stefansson K, North KE, IMcCarthy M, Hirschhorn JN, Ingelsson E, Loos RJF. 2010. Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index. Nature Genetics 42(11):937-948 DOI 10.1038/ng.686.
255. Srisai D, Gillum MP, Panaro BL, Zhang X-M, Kotchabhakdi N, Shulman GI, Ellacott KLJ, Cone RD. 2011. Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse. Endocrinology 152(3):890-902 DOI 10.1210/en.2010-0716.
256. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, Kraft P, Chen R, Kallberg HJ, Kurreeman FAS, Kathiresan S, Wijmenga C, Gregersen PK, Alfredsson L, Siminovitch KA, Worthington J, de Bakker PIW, Raychaudhuri S, Plenge RM. 2012. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nature Genetics 44(5):483-489 DOI 10.1038/ng.2232.
257. Stanford WL, Cohn JB, Cordes SP. 2001. Gene-trap mutagenesis: past, present and beyond. Nature Reviews. Genetics 2(10):756-768 DOI 10.1038/35093548.
258. Stäubert C, Tarnow P, Brumm H, Pitra C, Gudermann T, Grüters A, Schöneberg T, Biebermann H, Römpler H. 2007. Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor. Endocrinology 148(10):4642-4648 DOI 10.1210/en.2007-0138.
259. Stone S, Abkevich V, Hunt SC, Gutin A, Russell DL, Neff CD, Riley R, Frech GC, Hensel CH, Jammulapati S, Potter J, Sexton D, Tran T, Gibbs D, Iliev D, Gress R, Bloomquist B, Amatruda J, Peter Rae MM, Ted Adams D, Mark Skolnick H, Shattuck D. 2002. A major predisposition locus for severe obesity at 4p15-p14. American Journal of Human Genetics 70(6):1459-1468 DOI 10.1086/340670.
260. Stone S, Abkevich V, Russell DL, Riley R, Timms K, Tran T, TremD, Frank D, Jammulapati S, Neff CD, Iliev D, Gress R, He G, Frech GC, Adams TD, Skolnick MH, Lanchbury JS, Gutin A, Hunt SC, Shattuck D. 2006. TBC1D1 is a candidate for a severe obesity gene evidence for a gene/gene interaction in obesity predisposition. Human Molecular Genetics 15(18):2709-2720 DOI 10.1093/hmg/ddl204.
261. Strachan T, Read A. 1999. Genetic manipulation of animals. In: Human molecular genetics. vol. 2. New York: Wiley-Liss.
262. Stratigopoulos G, Leduc CA, Cremona ML, Chung WK, Leibel RL. 2011. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. The Journal of Biological Chemistry 286(3):2155-2170 DOI 10.1074/jbc. M110.188482.
263. Stratigopoulos G, Martin Carli JF, O'Day DR, Wang L, LeDuc CA, Lanzano P, Chung WK, Rosenbaum M, Egli D, Doherty DA, Leibel RL. 2014. Hypomorphism for RPGRIP1L, a ciliary gene vicinal to the FTO locus, causes increased adiposity in mice. Cell Metabolism 19(5):767-779 DOI 10.1016/j.cmet.2014.04.009.
264. Stutzmann F, Tan K, Vatin V, Dina C, Jouret B, Tichet J, Balkau B, Potoczna N, Horber F, O'Rahilly S, Farooqi IS, Froguel P, Meyre D. 2008. Prevalence of melanocortin-4 receptor deficiency in europeans their age-dependent penetrance in multigenerational pedigrees. Diabetes 57(September):2511-2518 DOI 10.2337/db08-0153.
265. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O, Tounian P, Levy-Marchal C, Buzzetti R, Pinelli L, Balkau B, Horber F, Bougneres P, Froguel P, Meyre D. 2007. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Human Molecular Genetics 16(15):1837-1844 DOI 10.1093/hmg/ddm132.
266. Stylianou IM, Christians JK, Keightley PD, Bünger L, Clinton M, Bulfield G, Horvat S. 2004. Genetic complexity of an obesity QTL (Fob3) revealed by detailed genetic mapping. Mammalian Genome: Official Journal of the International Mammalian Genome Society 15(6):472-481 DOI 10.1007/s00335-004-3039-z.
267. Styrkarsdottir U, Thorleifsson G, Helgadottir HT, Bomer N, Metrustry S, Bierma-Zeinstra S, Strijbosch AM, Evangelou E, Hart D, Stefansson K. 2014. Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nature Genetics 46(5):498-502 DOI 10.1038/ng.2957.
268. Sun N, Abil Z, Zhao H. 2012. Recent advances in targeted genome engineering in mammalian systems. Biotechnology Journal 7(9):1074-1087 DOI 10.1002/biot.201200038.
269. Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H. 1999. A new mouse model of spontaneous Diabetes derived from ddY strain. Experimental Animals 48(3):181-189 DOI 10.1538/expanim.48.181.
270. Svenson K, Bogue M, Peters L. 2003. Invited review: identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains. Journal of Applied Physiology 94:1650-1659.
271. Switzer NJ, Mangat HS, Karmali S. 2013. Current trends in obesity: body composition assessment, weight regulation, and emerging techniques in managing severe obesity. Journal of Interventional Gastroenterology 3(1):34-36 DOI 10.7178/jig.106.
272. Takeshita S, Suzuki T, Kitayama S, Moritani M. 2012. Bhlhe40, a potential diabetic modifier gene on Dbm1 locus, negatively controls myocyte fatty acid oxidation. Genes & Genetic Systems 87:253-264 DOI 10.1266/ggs.87.253.
273. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. 1995. Identification expression of a leptin receptor OB-R. Cell 83:1263-1271 DOI 10.1016/0092-8674(95)90151-5.
274. Teare MD, Barrett JH, Road BH, Sheffield S. 2005. Genetic Epidemiology 2 Genetic linkage studies. Lancet 366(9490):1036-1044 DOI 10.1016/S0140-6736(05)67382-5.
275. Terauchi Y, Matsui J, Suzuki R, Kubota N, Komeda K, Aizawa S, Eto K, Kimura S, Nagai R, Tobe K, Lienhard GE, Kadowaki T. 2003. Impact of genetic background ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice. The Journal of Biological Chemistry 278(16):14284-14290 DOI 10.1074/jbc. M211045200.
276. Thomas K, Capecchi M. 1987. Site-directed mutagenesis by gene targeting in mouse embroyonic stem cells. Cell 51:503-512 DOI 10.1016/0092-8674(87)90646-5.
277. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, SulemP, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, Jonsdottir T, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Jonsson F, Borch-Johnsen K, Hansen T, Andersen G, Jorgensen T, Lauritzen T, Aben KK, Verbeek A, Roeleveld N, Kampman E, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Becker DM, Gulcher J, Kiemeney LA, Pedersen O, Kong A, Thorsteinsdottir U, Stefansson K. 2009. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genetics 41(1):18-24 DOI 10.1038/ng.274.
278. Toye AA, Moir L, Hugill A, Bentley L, Quarterman J, Mijat V, Hough T, Goldsworthy M, Haynes A, Hunter AJ, Browne M, Spurr N, Cox RD. 2004. A new mouse model of type 2 diabetes produced by N-ethyl-nitrosourea mutagenesis is the result of a missense mutation in the glucokinase gene. Diabetes 53:1577-1583 DOI 10.2337/diabetes.53.6.1577.
279. Tung Y-CL, Ayuso E, Shan X, Bosch F, O'Rahilly S, Coll AP, Yeo GSH. 2010. Hypothalamicspecific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS ONE 5(1):e8771 DOI 10.1371/journal.pone.0008771.
280. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. 2010. Genome editing with engineered zinc finger nucleases. Nature Reviews. Genetics 11(9):636-646 DOI 10.1038/nrg2842.
281. Vaisse C, Clement K, Guy-grand B, Froguel P. 1998. A frameshift mutation in human MC4R is associated with a dominant form of obesity WRN, is a 3' ?5' exonuclease. Nature Genetics 20:113-114 DOI 10.1038/2407.
282. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, CooksonWO, Taylor MS, Rawlins J Nicholas P., Mott R, Flint J. 2006. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nature Genetics 38(8):879-887 DOI 10.1038/ng1840.
283. Vimaleswaran KS, Tachmazidou I, Zhao JH, Hirschhorn JN, Dudbridge F, Loos RJF. 2012. Candidate genes for obesity-susceptibility show enriched association within a large genome-Wide association study for BMI. Human Molecular Genetics 21(20):4537-4542 DOI 10.1093/hmg/dds283.
284. Visscher PM, Brown MA, McCarthy MI, Yang J. 2012. Five years of GWAS discovery. American Journal of Human Genetics 90(1):7-24 DOI 10.1016/j.ajhg.2011.11.029.
285. Vogel H, Scherneck S, Kanzleiter T, Benz V, Kluge R, Stadion M, Kryvych S, Bluher M, Kloting N, Joost H-G, Schurmann A. 2012. Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11ß-hydroxysteroid dehydrogenase type 1 expression development of obesity. Human Molecular Genetics 21(17):3845-3857 DOI 10.1093/hmg/dds213.
286. Vuillaume M-L, Naudion S, Banneau G, Diene G, Cartault A, Cailley D, Bouron J, Toutain J, Bourrouillou G, Vigouroux A, Bouneau L, Nacka F, Kieffer I, Arveiler B, Knoll-Gellida A, Babin PJ, Bieth E, Jouret B, Julia S, Sarda P, Geneviéve D, Faivre L, Lacombe D, Barat P, Tauber M, Delrue M-A, Rooryck C. 2014. New candidate loci identified by array-CGH in a cohort of 100 children presenting with syndromic obesity. American Journal of Medical Genetics. Part A 164A(8):1965-1975 DOI 10.1002/ajmg.a.36587.
287. Wabitsch M, Funcke J-B, Lennerz B, Kuhnle-Krahl U, Lahr G, Debatin K-M, Vatter P, Gierschik P, Moepps B, Fischer-Posovszky P. 2015. Biologically inactive leptin and early-onset extreme obesity. New England Journal of Medicine 372:48-54 DOI 10.1056/NEJMoa1406653.
288. Walters RG, Jacquemont S, Valsesia A, Smith AJDE, Martinet D. 2010. A novel highly-penetrant form of obesity due to microdeletions on chromosome 16p11.2. Nature 463(7281):671-675 DOI 10.1038/nature08727.
289. Wang F, Mullican SE, Dispirito JR, Peed LC, Lazar MA. 2013. Lipoatrophy and severe metabolic disturbance in mice with fat-speci fi c deletion of PPAR ?. Proceedings of the National Academy of Sciences of the United States of America 110(46):18656-18661 DOI 10.1073/pnas.1314863110.
290. Warden CH, Fisler JS, Pace MJ, Svenson KL, Lusis AJ. 1993. Coincidence of genetic loci for plasma cholesterol levels and obesity in a multifactorial mouse model. The Journal of Clinical Investigation 92(2):773-779 DOI 10.1172/JCI116649.
291. Warden CH, Fisler JS, Shoemaker SM, Wen PZ, Svenson KL, Pace MJ, Lusis AJ. 1995. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. The Journal of Clinical Investigation 95(4):1545-1552 DOI 10.1172/JCI117827.
292. Wheeler E, Huang N, Bochukova EG, Keogh JM, Lindsay S, Garg S, Henning E, Blackburn H, Loos RJF, Wareham NJ, O'Rahilly S, Hurles ME, Barroso I, Farooqi IS. 2013. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nature Genetics 45(5):513-517 DOI 10.1038/ng.2607.
293. Willer CJ, Speliotes EK, Loos RJF, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, Lettre G, Lim N, Lyon HN, McCarroll SA, Papadakis K, Qi L, Randall JC, Roccasecca RM, Sanna S, Scheet P, Weedon MN, Wheeler E, Zhao JH, Jacobs LC, Prokopenko I, Soranzo N, Tanaka T, Timpson NJ, Almgren P, Bennett A, Bergman RN, Bingham SA, Bonnycastle LL, Brown M, Burtt NP, Chines P, Coin L, Collins FS, Connell JM, Cooper C, Smith GD, Dennison EM, Deodhar P, Elliott P, Erdos MR, Estrada K, Evans DM, Gianniny L, Gieger C, Gillson CJ, Guiducci C, Hackett R, Hadley D, Hall AS, Havulinna AS, Hebebrand J, Hofman A, Isomaa B, Jacobs KB, Johnson T, Jousilahti P, Jovanovic Z, Khaw K-T, Kraft P, Kuokkanen M, Kuusisto J, Laitinen J, Lakatta EG, Luan Jian'an, Luben RN, Mangino M, McArdle WL, Meitinger T, Mulas A, Munroe PB, Narisu N, Ness AR, Northstone K, O'Rahilly S, Purmann C, Rees MG, Ridderstråle M, Ring SM, Rivadeneira F, Ruokonen A, Sandhu MS, Saramies J, Scott LJ, Scuteri A, Silander K, Sims MA, Song K, Stephens J, Stevens S, Stringham HM, Tung YCL, Valle TT, Van Duijn CM, Vimaleswaran KS, Vollenweider P, Waeber G, Wallace C, Watanabe RM, Waterworth DM, Watkins N, Witteman JCM, Zeggini E, Zhai G, Zillikens MC, Altshuler D, Caulfield MJ, Chanock SJ, Farooqi IS, Ferrucci L, Guralnik JM, Hattersley AT, Hu FB, Jarvelin M-R, Laakso M, Mooser V, Ong KK, Ouwehand WH, Salomaa V, Samani NJ, Spector TD, Tuomi T, Tuomilehto J, Uda M, Uitterlinden AG, Wareham NJ, Deloukas P, Frayling TM, Groop LC, Hayes RB, Hunter DJ, Mohlke KL, Peltonen L, Schlessinger D, Strachan DP, Wichmann H-E, McCarthy MI, Boehnke M, Barroso I, Abecasis GR, Hirschhorn JN. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics 41(1):25-34 DOI 10.1038/ng.287.
294. World Health Organization. 2011. Obesity and overweight: factsheet. Geneva: World Health Organization. Available at http://www.who.int/mediacentre/factsheets/fs311/en/.
295. Wuschke S, Dahm S, Schmidt C, Joost H-G, Al-Hasani H. 2007. A meta-analysis of quantitative trait loci associated with body weight and adiposity in mice. International Journal of Obesity 31(5):829-841 DOI 10.1038/sj.ijo.0803473.
296. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, Shen K, Wu S, Lin X, Zhang G, Wang C, Wang S, Lu H, Fang Q, Shi Y, Zhang R, Xu J, Weng Q. 2004. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 53(1):228-234 DOI 10.2337/diabetes.53.1.228.
297. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. 2003. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience 6(7):736-742 DOI 10.1038/nn1073.
298. Yamamura K, Araki K. 2008. Gene trap mutagenesis in mice: new perspectives and tools in cancer research. Cancer Science 99(1):1-6 DOI 10.1111/j.1349-7006.2007.00611.x.
299. Yang X, Deignan JL, Qi H, Zhu J, Qian S, Zhong J, Torosyan G, Majid S, Falkard B, Kleinhanz RR, Karlsson J, Castellani LW, Mumick S, Wang K, Xie T, Coon M, Zhang C, Estrada-Smith D, Farber CR, Wang SS, van Nas A, Ghazalpour A, Zhang B, MacNeil DJ, Lamb JR, Dipple KM, Reitman ML, Mehrabian M, Lum PY, Schadt EE, Lusis AJ, Drake TA. 2009. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nature Genetics 41(4):415-423 DOI 10.1038/ng.325.
300. Yang D, Jiang Y, He F. 2009. An integrated view of the correlations between genomic and phenomic variables. Journal of Genetics and Genomics 36(11):645-651 DOI 10.1016/S1673-8527(08)60156-3.
301. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. 1999. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nature Medicine 5(9):1066-1070 DOI 10.1038/12506.
302. Yazbek SN, Buchner DA, Geisinger JM, Burrage LC, Spiezio SH, Zentner GE, Hsieh C-W, Scacheri PC, Croniger CM, Nadeau JH. 2011. Deep congenic analysis identifies many strong context-dependent QTLs one of which Slc35b4 regulates obesity glucose homeostasis. Genome Research 21(7):1065-1073 DOI 10.1101/gr.120741.111.
303. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. 1998. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genetics 20(2):111-112 DOI 10.1038/2404.
304. Yeo GSH, Connie Hung C-C, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O'Rahilly S, Farooqi IS. 2004. A de novo mutation affecting human TrkB associated with severe obesity developmental delay. Nature Neuroscience 7(11):1187-1189 DOI 10.1038/nn1336.
305. Yi N, Diament A, Chiu S, Kim K, Allison DB, Fisler JS, Warden CH. 2004. Characterization of epistasis influencing complex spontaneous obesity in the BSB model. Genetics 167(1):399-409 DOI 10.1534/genetics.167.1.399.
306. Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. 2014. Non-viral vectors for gene-based therapy. Nature Reviews. Genetics 15(8):541-555 DOI 10.1038/nrg3763.
307. Yoganathan P, Karunakaran S, Clee Ho. 2012. Nutritional regulation of genome-wide association obesity genes in a tissue-dependent manner. Nutrition and Metabolism 9(1):1 DOI 10.1186/1743-7075-9-65.
308. Yourshaw M, Solorzano-Vargas RS, Pickett LA, Lindberg I, Wang J, Cortina G, Pawlikowska- Haddal A, Baron H, Venick RS, Nelson SF, Martín MG. 2013. Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus. Journal of Pediatric Gastroenterology and Nutrition 57(6):759-767 DOI 10.1097/MPG.0b013e3182a8ae6c.
309. Zegers D, Beckers S, Hendrickx R. 2013. Prevalence of rare MC3R variants in obese cases and lean controls. Endocrine 44(2):386-390 DOI 10.1007/s12020-012-9862-1.
310. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 DOI 10.1038/372425a0.
311. Zhang F, Wen Y, Guo X. 2014. CRISPR/Cas9 for genome editing: progress, implications and challenges. Human Molecular Genetics 15(23):1-7 DOI 10.1093/hmg/ddu125.
312. Zhu M, Zhao S. 2007. Candidate gene identification approach: progress and challenges. International Journal of Biological Sciences 3(7):420-427 DOI 10.7150/ijbs.3.420.
313. Zhu X, Zhou A, Dey A, NorrbomC, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ, Steiner DF. 2002. Disruption of PC1/3 expression in mice causes dwarfism multiple neuroendocrine peptide processing defects. Proceedings of the National Academy of Sciences of the United States of America 99(16):10293-10298 DOI 10.1073/pnas.162352599.
314. Zou F, Gelfond JAL, Airey DC, Lu L, Manly KF, Williams RW, Threadgill DW. 2005. Quantitative trait locus analysis using recombinant inbred intercrosses: theoretical and empirical considerations. Genetics 170:1299-1311 DOI 10.1534/genetics.104.035709.